HomeREGULATORY
REGULATORY

Chuikyo Reps Chide Delay in Parmodia Listing
(May.17.2018)

Chuikyo Healthcare Provider Rep Junichi Matsumoto (right)
Payer and healthcare provider reps of a key reimbursement policy panel on May 16 questioned the delay in the listing of Kowa’s hyperlipidemia treatment Parmodia (pemafibrate), which was caused by prolonged price negotiations between the company and regulatory authorities ...
(LOG IN FOR FULL STORY)

Notice

 The next ebook update will be provided on August 20.

News Calendar